Gegenanzeigen · Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)
Adjupanrix suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) · Abschnitt 4.3 · PDF-Seite 3
HOS-212684 · Präparat HOS-154960
History of an anaphylactic (i.e. life-threatening) reaction to any of the constituents or trace residues (egg and chicken protein, ovalbumin, formaldehyde, gentamicin sulphate and sodium deoxycholate) of this vaccine. However, in a pandemic situation, it may be appropriate to give the vaccine, provided that facilities for resuscitation are immediately available in case of need. See section 4.4.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): sodium (HOS-109681) deoxycholate (HOS-212689) ovalbumin (HOS-153337) formaldehyde (HOS-091110) gentamicin (HOS-091173)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-12-17T01:00:00Z · SHA-256 336e8653754d4ede45edd66dee9c0f9a4f8e73b2206a4806ebd9d39bb5fe137a · Passage 45bafe79602bcecb46e0940ede4e2f6c2402778ad6166235b579135eea717b3f · Zeichen 0–397 im Abschnitt